Hsbc Holdings PLC Has $170.41 Million Position in Marsh & McLennan Companies, Inc. $MRSH

Hsbc Holdings PLC raised its stake in shares of Marsh & McLennan Companies, Inc. (NYSE:MRSHFree Report) by 3.7% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,022,077 shares of the financial services provider’s stock after purchasing an additional 36,397 shares during the period. Hsbc Holdings PLC’s holdings in Marsh & McLennan Companies were worth $170,412,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of MRSH. Focus Partners Advisor Solutions LLC bought a new position in Marsh & McLennan Companies in the 2nd quarter valued at $2,153,000. Swiss Life Asset Management Ltd boosted its stake in Marsh & McLennan Companies by 9.5% during the 4th quarter. Swiss Life Asset Management Ltd now owns 134,542 shares of the financial services provider’s stock worth $24,960,000 after acquiring an additional 11,648 shares during the last quarter. Daiichi Life Insurance Co. Ltd. bought a new stake in shares of Marsh & McLennan Companies in the 2nd quarter valued at $3,880,000. Korea Investment CORP acquired a new stake in shares of Marsh & McLennan Companies during the second quarter worth about $46,856,000. Finally, Bank of Nova Scotia acquired a new stake in Marsh & McLennan Companies during the 2nd quarter worth approximately $20,681,000. 87.99% of the stock is currently owned by institutional investors and hedge funds.

Marsh & McLennan Companies Stock Performance

MRSH stock opened at $193.59 on Wednesday. Marsh & McLennan Companies, Inc. has a 52 week low of $156.60 and a 52 week high of $207.82. The company has a 50-day simple moving average of $180.99. The firm has a market capitalization of $92.38 billion, a P/E ratio of 23.67, a PEG ratio of 2.79 and a beta of 0.59. The company has a debt-to-equity ratio of 1.22, a current ratio of 1.14 and a quick ratio of 1.14.

Marsh & McLennan Companies (NYSE:MRSHGet Free Report) last announced its quarterly earnings data on Tuesday, July 21st. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.89 by $0.07. Marsh & McLennan Companies had a net margin of 14.24% and a return on equity of 32.67%. The firm had revenue of $7.28 billion for the quarter. The company’s revenue for the quarter was up 6.2% compared to the same quarter last year. On average, analysts forecast that Marsh & McLennan Companies, Inc. will post 10.43 EPS for the current year.

Marsh & McLennan Companies Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, August 14th. Investors of record on Thursday, July 23rd were issued a dividend of $0.99 per share. This is a boost from Marsh & McLennan Companies’s previous quarterly dividend of $0.90. The ex-dividend date of this dividend was Thursday, July 23rd. This represents a $3.96 annualized dividend and a dividend yield of 2.0%. Marsh & McLennan Companies’s payout ratio is presently 48.41%.

Insider Activity at Marsh & McLennan Companies

In other news, SVP Paul Beswick sold 713 shares of the stock in a transaction on Wednesday, July 29th. The stock was sold at an average price of $198.00, for a total value of $141,174.00. Following the completion of the transaction, the senior vice president directly owned 16,376 shares in the company, valued at approximately $3,242,448. This represents a 4.17% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Martin South sold 7,100 shares of the business’s stock in a transaction on Tuesday, July 28th. The stock was sold at an average price of $189.99, for a total value of $1,348,929.00. Following the sale, the insider owned 16,632 shares in the company, valued at $3,159,913.68. This represents a 29.92% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 36,469 shares of company stock valued at $6,291,345 in the last quarter. 0.38% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on MRSH. UBS Group raised their price target on shares of Marsh & McLennan Companies from $212.00 to $216.00 and gave the stock a “buy” rating in a research note on Monday, July 27th. Citigroup downgraded shares of Marsh & McLennan Companies from a “buy” rating to a “neutral” rating and set a $200.00 price objective for the company. in a research report on Wednesday, July 22nd. Piper Sandler dropped their target price on shares of Marsh & McLennan Companies from $190.00 to $182.00 and set a “neutral” rating on the stock in a report on Tuesday, May 26th. Mizuho boosted their price target on Marsh & McLennan Companies from $197.00 to $201.00 and gave the stock a “neutral” rating in a research report on Wednesday, July 22nd. Finally, JPMorgan Chase & Co. raised their price objective on Marsh & McLennan Companies from $206.00 to $212.00 and gave the company an “overweight” rating in a research report on Monday, July 13th. One research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, eleven have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $203.50.

Check Out Our Latest Report on MRSH

Marsh & McLennan Companies Company Profile

(Free Report)

Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.

Featured Articles

Want to see what other hedge funds are holding MRSH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. (NYSE:MRSHFree Report).

Institutional Ownership by Quarter for Marsh & McLennan Companies (NYSE:MRSH)

Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.